Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Skuli

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Oncotarget|November 22, 2017
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an updateLaure Malric, Sylvie Monferran, Julia Gilhodes, et al.
Molecular Cancer Therapeutics|July 3, 2019
The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?Joshua Casaos, Noah L Gorelick, Sakibul Huq, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 12, 2019
Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastomaManabu Natsumeda, Yang Liu, Satoshi Nakata, et al.
Blood|April 10, 2015
The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viabilityBryan L Krock, Tzipora S Eisinger-Mathason, Dionysios N Giannoukos, et al.
Frontiers in Immunology|November 21, 2018
Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental ColitisNan Lin, Jessica E S Shay, Hong Xie, et al.
Plos One|April 14, 2015
Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseJulie Sesen, Perrine Dahan, Sarah J Scotland, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2015
Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesisT S Karin Eisinger-Mathason, Vera Mucaj, Kevin M Biju, et al.
Cancer Cell|November 17, 2012
ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivationGuoliang Qing, Bo Li, Annette Vu, et al.
NAR Cancer|July 28, 2021
Translation reprogramming by eIF3 linked to glioblastoma resistanceJuliette Bertorello, Julie Sesen, Julia Gilhodes, et al.
Carcinogenesis|January 11, 2014
Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancerJessica E S Shay, Hongxia Z Imtiyaz, Sharanya Sivanand, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Oncotarget|November 22, 2017
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an updateLaure Malric, Sylvie Monferran, Julia Gilhodes, et al.
Molecular Cancer Therapeutics|July 3, 2019
The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?Joshua Casaos, Noah L Gorelick, Sakibul Huq, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 12, 2019
Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastomaManabu Natsumeda, Yang Liu, Satoshi Nakata, et al.
Blood|April 10, 2015
The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viabilityBryan L Krock, Tzipora S Eisinger-Mathason, Dionysios N Giannoukos, et al.
Frontiers in Immunology|November 21, 2018
Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental ColitisNan Lin, Jessica E S Shay, Hong Xie, et al.
Plos One|April 14, 2015
Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseJulie Sesen, Perrine Dahan, Sarah J Scotland, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2015
Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesisT S Karin Eisinger-Mathason, Vera Mucaj, Kevin M Biju, et al.
Cancer Cell|November 17, 2012
ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivationGuoliang Qing, Bo Li, Annette Vu, et al.
NAR Cancer|July 28, 2021
Translation reprogramming by eIF3 linked to glioblastoma resistanceJuliette Bertorello, Julie Sesen, Julia Gilhodes, et al.
Carcinogenesis|January 11, 2014
Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancerJessica E S Shay, Hongxia Z Imtiyaz, Sharanya Sivanand, et al.
Pageof 7